Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Cinedigm announces contract renewal with Crown Media Family Network » 10:03
10/11/21
10/11
10:03
10/11/21
10:03
CIDM

Cinedigm

$2.47 /

+0.035 (+1.44%)

Cinedigm announced that…

Cinedigm announced that the company has extended its agreement with Hallmark Channel to distribute the network's content on TVOD and Physical. The two companies have worked together for nearly a decade and have grown the transactional business outpacing industry trends. The companie said, "The growth can be attributed to the superior quality of Hallmark's original films and scripted series. With a vast library, Hallmark has found a passionate audience in both the physical market, as well as on digital platforms like Amazon, Apple and VUDU. As part of the renewal, Cinedigm and Hallmark will open up digital rental on select titles for the first time ever."

ShowHide Related Items >><<
CIDM Cinedigm
$2.47 /

+0.035 (+1.44%)

CIDM Cinedigm
$2.47 /

+0.035 (+1.44%)

08/02/21 Alliance Global Partners
Cinedigm price target raised to $3.25 from $3.00 at Alliance Global Partners
05/12/21 Alliance Global Partners
Alliance Global Partners bullish on Cinedigm, sees Roku among catalysts
01/21/21 Alliance Global Partners
Cinedigm price target raised to $3 from $2 at Alliance Global Partners
10/16/20 Alliance Global Partners
Cinedigm initiated with a Buy at Alliance Global Partners
CIDM Cinedigm
$2.47 /

+0.035 (+1.44%)

CIDM Cinedigm
$2.47 /

+0.035 (+1.44%)

Over a month ago
Conference/Events
H.C. Wainwright to hold a virtual conference » 04:55
09/15/21
09/15
04:55
09/15/21
04:55
ABUS

Arbutus Biopharma

$4.25 /

-0.005 (-0.12%)

, ACER

Acer Therapeutics

$2.53 /

-0.1 (-3.80%)

, ACET

Adicet Bio

$7.28 /

-0.47 (-6.06%)

, CIDM

Cinedigm

$2.16 /

+0.06 (+2.86%)

, TMDI

Titan Medical

$1.59 /

-0.025 (-1.55%)

, SLGG

Super League Gaming

$3.60 /

-0.21 (-5.51%)

, SLRX

Salarius Pharmaceuticals

$1.03 /

+ (+0.00%)

, SMLR

Semler Scientific

$106.60 /

-0.43 (-0.40%)

, ZYNE

Zynerba

$4.31 /

-0.135 (-3.04%)

, TARA

Protara Therapeutics

$7.19 /

-0.46 (-6.01%)

, TCON

Tracon Pharmaceuticals

$3.73 /

-0.11 (-2.86%)

, RUBY

Rubius Therapeutics

$19.44 /

-0.68 (-3.38%)

, PLSE

Pulse Biosciences

$20.46 /

-0.26 (-1.25%)

, PNT

Point Biopharma

$9.34 /

+0.31 (+3.43%)

, IMRA

Imara

$4.12 /

-0.14 (-3.29%)

, IMAB

I-Mab

$68.57 /

+0.32 (+0.47%)

, KBNT

Kubient

$3.50 /

+0.07 (+2.04%)

, LPTX

Leap Therapeutics

$1.79 /

+0.01 (+0.56%)

, LUMO

Lumos Pharma

$10.10 /

-0.45 (-4.27%)

, LYRA

Lyra Therapeutics

$8.18 /

-0.37 (-4.33%)

, EDAP

EDAP TMS

$6.25 /

+0.255 (+4.25%)

, EXEL

Exelixis

$20.14 /

-0.11 (-0.54%)

, GMTX

Gemini Therapeutics

$4.54 /

-0.045 (-0.98%)

, BLU

Bellus Health

$5.56 /

+0.79 (+16.56%)

, CGRN

Capstone Green Energy

$4.45 /

-0.06 (-1.33%)

, DYAI

Dyadic International

$5.34 /

-0.41 (-7.13%)

, AGRI

AgriFORCE Growing Systems

$2.32 /

-0.19 (-7.57%)

, ANEB

Anebulo Pharmaceuticals

$6.96 /

-0.06 (-0.85%)

, VIVE

Viveve

$2.39 /

-0.07 (-2.85%)

, ZIOP

Ziopharm

$1.63 /

-0.195 (-10.68%)

23rd Annual Global…

23rd Annual Global Investment Virtual Conference to be held on September 13-15.Webcast Link

ShowHide Related Items >><<
ZYNE Zynerba
$4.31 /

-0.135 (-3.04%)

ZIOP Ziopharm
$1.63 /

-0.195 (-10.68%)

VIVE Viveve
$2.39 /

-0.07 (-2.85%)

TMDI Titan Medical
$1.59 /

-0.025 (-1.55%)

TCON Tracon Pharmaceuticals
$3.73 /

-0.11 (-2.86%)

TARA Protara Therapeutics
$7.19 /

-0.46 (-6.01%)

SLRX Salarius Pharmaceuticals
$1.03 /

+ (+0.00%)

SLGG Super League Gaming
$3.60 /

-0.21 (-5.51%)

RUBY Rubius Therapeutics
$19.44 /

-0.68 (-3.38%)

PNT Point Biopharma
$9.34 /

+0.31 (+3.43%)

PLSE Pulse Biosciences
$20.46 /

-0.26 (-1.25%)

LYRA Lyra Therapeutics
$8.18 /

-0.37 (-4.33%)

LUMO Lumos Pharma
$10.10 /

-0.45 (-4.27%)

LPTX Leap Therapeutics
$1.79 /

+0.01 (+0.56%)

KBNT Kubient
$3.50 /

+0.07 (+2.04%)

IMRA Imara
$4.12 /

-0.14 (-3.29%)

IMAB I-Mab
$68.57 /

+0.32 (+0.47%)

GMTX Gemini Therapeutics
$4.54 /

-0.045 (-0.98%)

EXEL Exelixis
$20.14 /

-0.11 (-0.54%)

EDAP EDAP TMS
$6.25 /

+0.255 (+4.25%)

DYAI Dyadic International
$5.34 /

-0.41 (-7.13%)

CIDM Cinedigm
$2.16 /

+0.06 (+2.86%)

CGRN Capstone Green Energy
$4.45 /

-0.06 (-1.33%)

BLU Bellus Health
$5.56 /

+0.79 (+16.56%)

AGRI AgriFORCE Growing Systems
$2.32 /

-0.19 (-7.57%)

ACET Adicet Bio
$7.28 /

-0.47 (-6.06%)

ACER Acer Therapeutics
$2.53 /

-0.1 (-3.80%)

ABUS Arbutus Biopharma
$4.25 /

-0.005 (-0.12%)

ABUS Arbutus Biopharma
$4.25 /

-0.005 (-0.12%)

06/28/21 JMP Securities
Arbutus EASL updates still support progress in Chronic HBV, says JMP Securities
03/10/21 B. Riley
Arbutus Biopharma price target lowered to $7 from $8 at B. Riley Securities
12/17/20 H.C. Wainwright
Arbutus Biopharma initiated with a Buy at H.C. Wainwright
09/15/20 Chardan
Arbutus HBV data 'could represent a turning point,' says Chardan
ACER Acer Therapeutics
$2.53 /

-0.1 (-3.80%)

06/10/21 William Blair
Acer's increased pipeline visibility is encouraging, says William Blair
ACET Adicet Bio
$7.28 /

-0.47 (-6.06%)

05/17/21 BTIG
Adicet Bio initiated with a Buy at BTIG
05/17/21 BTIG
Adicet Bio initiated with a Buy at BTIG
04/29/21
Fly Intel: Top five analyst initiations
04/29/21 JonesTrading
Adicet Bio initiated with a Buy at JonesTrading
CIDM Cinedigm
$2.16 /

+0.06 (+2.86%)

08/02/21 Alliance Global Partners
Cinedigm price target raised to $3.25 from $3.00 at Alliance Global Partners
05/12/21 Alliance Global Partners
Alliance Global Partners bullish on Cinedigm, sees Roku among catalysts
01/21/21 Alliance Global Partners
Cinedigm price target raised to $3 from $2 at Alliance Global Partners
10/16/20 Alliance Global Partners
Cinedigm initiated with a Buy at Alliance Global Partners
TMDI Titan Medical
$1.59 /

-0.025 (-1.55%)

04/06/21 Oppenheimer
Opco starts 'attractive micro-cap play' Titan Medical with Outperform
04/06/21 Oppenheimer
Titan Medical initiated with an Outperform at Oppenheimer
SLGG Super League Gaming
$3.60 /

-0.21 (-5.51%)

05/27/21 H.C. Wainwright
Super League Gaming initiated with a Buy at H.C. Wainwright
03/01/21 Maxim
Super League Gaming initiated with a Buy at Maxim
03/01/21 Maxim
Super League Gaming initiated with a Buy at Maxim
02/09/21 Alliance Global Partners
Super League downgraded on 'rich' valuation at Alliance Global
SLRX Salarius Pharmaceuticals
$1.03 /

+ (+0.00%)

08/25/21
Fly Intel: Top five analyst initiations
08/25/21 H.C. Wainwright
Salarius Pharmaceuticals initiated with a Buy at H.C. Wainwright
SMLR Semler Scientific
$106.60 /

-0.43 (-0.40%)

05/04/21 B. Riley
Semler Scientific price target raised to $151 from $147 at B. Riley
04/27/21 B. Riley
Semler Scientific transferred with Buy, $147 target at B. Riley
03/02/21 B. Riley
Semler Scientific price target raised to $147 from $121 at B. Riley Securities
02/25/21 B. Riley
Semler Scientific price target raised to $121 from $100 at B. Riley Securities
ZYNE Zynerba
$4.31 /

-0.135 (-3.04%)

06/25/21 Alliance Global Partners
Cannabis selloff brings buying opportunities, says Alliance Global
05/06/21 Cantor Fitzgerald
Zynerba price target raised to $8 from $6 at Cantor Fitzgerald
03/29/21 Stifel
Stifel says New York adult use cannabis market represents $5B opportunity
03/10/21 Roth Capital
Zynerba price target lowered to $7.25 from $8.00 at Roth Capital
TARA Protara Therapeutics
$7.19 /

-0.46 (-6.01%)

06/04/21 H.C. Wainwright
Protara Therapeutics initiated with a Buy at H.C. Wainwright
04/26/21 Oppenheimer
Protara Therapeutics price target lowered to $32 from $43 at Oppenheimer
10/19/20 Cowen
Protara Therapeutics initiated with an Outperform at Cowen
TCON Tracon Pharmaceuticals
$3.73 /

-0.11 (-2.86%)

06/04/21
Fly Intel: Top five analyst initiations
06/04/21 Alliance Global Partners
Tracon Pharmaceuticals initiated with a Buy at Alliance Global Partners
04/16/21 BTIG
BTIG upgrades Tracon to Buy with $14 target on Envafolimab progress
04/16/21 BTIG
Tracon Pharmaceuticals upgraded to Buy from Neutral at BTIG
RUBY Rubius Therapeutics
$19.44 /

-0.68 (-3.38%)

03/15/21 H.C. Wainwright
Rubius Therapeutics price target raised to $40 from $28 at H.C. Wainwright
10/14/20 JPMorgan
Rubius Therapeutics resumed with a Neutral at JPMorgan
PLSE Pulse Biosciences
$20.46 /

-0.26 (-1.25%)

07/26/21 Stephens
Pulse Biosciences a 'compelling and durable story,' says Stephens
07/26/21 Stephens
Pulse Biosciences initiated with an Overweight at Stephens
03/11/21 Maxim
Pulse Biosciences initiated with a Buy at Maxim
03/11/21 Maxim
Pulse Biosciences initiated with a Buy at Maxim
PNT Point Biopharma
$9.34 /

+0.31 (+3.43%)

07/29/21 Cowen
Cowen starts Point Biopharma at Outperform
07/29/21 Cowen
Point Biopharma initiated with an Outperform at Cowen
07/27/21 Jefferies
Point Biopharma initiated with a Hold at Jefferies
07/26/21 Piper Sandler
Point Biopharma initiated with an Overweight at Piper Sandler
IMRA Imara
$4.12 /

-0.14 (-3.29%)

08/11/21 Morgan Stanley
Imara downgraded to Equal Weight from Overweight at Morgan Stanley
08/11/21 Morgan Stanley
Imara downgraded to Equal Weight from Overweight at Morgan Stanley
03/08/21 SVB Leerink
Imara price target lowered to $42 from $59 at SVB Leerink
01/06/21 SVB Leerink
Imara selloff a potential buying opportunity, says SVB Leerink
IMAB I-Mab
$68.57 /

+0.32 (+0.47%)

09/03/21 Cantor Fitzgerald
Cantor Fitzgerald positive on I-Mab following 'solid' first half
09/01/21 H.C. Wainwright
I-Mab price target raised to $95 from $75 at H.C. Wainwright
07/26/21 Cantor Fitzgerald
I-Mab's overdone weakness a buying opportunity, says Cantor Fitzgerald
07/13/21 Cantor Fitzgerald
I-Mab price target raised to $95 from $90 at Cantor Fitzgerald
KBNT Kubient
$3.50 /

+0.07 (+2.04%)

08/17/21 Maxim
Kubient price target lowered to $9 from $13 at Maxim
03/26/21 Maxim
Kubient price target raised to $13 from $10 at Maxim
10/27/20 Maxim
Kubient initiated with a Buy at Maxim
LPTX Leap Therapeutics
$1.79 /

+0.01 (+0.56%)

09/13/21 Raymond James
Leap Therapeutics price target raised to $4 from $3 at Raymond James
09/13/21 Piper Sandler
Leap combo sees 'strong' early response rate, says Piper Sandler
06/03/21 Baird
Leap Therapeutics transferred with Outperform at Baird
05/17/21 Piper Sandler
Leap Therapeutics price target lowered to $4 from $6 at Piper Sandler
LUMO Lumos Pharma
$10.10 /

-0.45 (-4.27%)

08/05/21 Piper Sandler
Lumos shares trading below cash, says Piper Sandler
07/22/21 Roth Capital
Lumos Pharma price target lowered to $35 from $51 at Roth Capital
07/21/21 Piper Sandler
Piper says Lumos Pharma's OraGrowtH210 trial delay 'not a problem'
07/21/21 H.C. Wainwright
Lumos Pharma price target lowered to $27 from $34 at H.C. Wainwright
LYRA Lyra Therapeutics
$8.18 /

-0.37 (-4.33%)

12/07/20 BofA
Lyra Therapeutics price target raised to $26 from $19 at BofA
EDAP EDAP TMS
$6.25 /

+0.255 (+4.25%)

04/28/21
Fly Intel: Top five analyst initiations
04/28/21 Piper Sandler
EDAP TMS initiated with an Overweight at Piper Sandler
04/01/21 H.C. Wainwright
EDAP TMS price target raised to $12 from $10 at H.C. Wainwright
01/25/21 Lake Street
EDAP TMS initiated with a Buy at Lake Street
EXEL Exelixis
$20.14 /

-0.11 (-0.54%)

08/06/21 H.C. Wainwright
Exelixis price target raised to $64 from $35 at H.C. Wainwright
06/29/21 H.C. Wainwright
Exelixis price target lowered to $35 from $47 at H.C. Wainwright
06/29/21 Oppenheimer
Exelixis price target lowered to $27 from $35 at Oppenheimer
06/28/21 Piper Sandler
Exelixis selloff on trial miss an overreaction, says Piper Sandler
GMTX Gemini Therapeutics
$4.54 /

-0.045 (-0.98%)

06/23/21 Stifel
Gemini's negative stock reaction to GEM103 data overdone, says Stifel
04/08/21 SVB Leerink
SVB Leerink bullish on Gemini Therapeutics, initiates with an Outperform
04/08/21 SVB Leerink
Gemini Therapeutics initiated with an Outperform at SVB Leerink
03/03/21 Jefferies
Gemini Therapeutics initiated with a Buy at Jefferies
BLU Bellus Health
$5.56 /

+0.79 (+16.56%)

09/14/21 BTIG
Bellus Health price target raised to $13 from $9 at BTIG
09/14/21 H.C. Wainwright
Bellus Health price target raised to $14 from $10 at H.C. Wainwright
07/29/21 BTIG
Bellus Health initiated with a Buy at BTIG
01/29/21 RBC Capital
Bellus Health initiated with an Outperform at RBC Capital
CGRN Capstone Green Energy
$4.45 /

-0.06 (-1.33%)

DYAI Dyadic International
$5.34 /

-0.41 (-7.13%)

AGRI AgriFORCE Growing Systems
$2.32 /

-0.19 (-7.57%)

ANEB Anebulo Pharmaceuticals
$6.96 /

-0.06 (-0.85%)

05/25/21 Benchmark
Anebulo Pharmaceuticals initiated with a Buy at Benchmark
VIVE Viveve
$2.39 /

-0.07 (-2.85%)

01/29/21 Alliance Global Partners
Viveve initiated with a Buy at Alliance Global Partners
ZIOP Ziopharm
$1.63 /

-0.195 (-10.68%)

08/10/21 Raymond James
Ziopharm downgraded to Market Perform from Outperform at Raymond James
08/10/21 Lake Street
Ziopharm price target lowered to $3.50 from $7 at Lake Street
08/10/21 Raymond James
Ziopharm downgraded to Market Perform from Outperform at Raymond James
08/09/21 Raymond James
Ziopharm downgraded to Market Perform from Outperform at Raymond James
ZYNE Zynerba
$4.31 /

-0.135 (-3.04%)

TCON Tracon Pharmaceuticals
$3.73 /

-0.11 (-2.86%)

TARA Protara Therapeutics
$7.19 /

-0.46 (-6.01%)

SLRX Salarius Pharmaceuticals
$1.03 /

+ (+0.00%)

RUBY Rubius Therapeutics
$19.44 /

-0.68 (-3.38%)

PNT Point Biopharma
$9.34 /

+0.31 (+3.43%)

PLSE Pulse Biosciences
$20.46 /

-0.26 (-1.25%)

LYRA Lyra Therapeutics
$8.18 /

-0.37 (-4.33%)

LUMO Lumos Pharma
$10.10 /

-0.45 (-4.27%)

LPTX Leap Therapeutics
$1.79 /

+0.01 (+0.56%)

KBNT Kubient
$3.50 /

+0.07 (+2.04%)

IMRA Imara
$4.12 /

-0.14 (-3.29%)

GMTX Gemini Therapeutics
$4.54 /

-0.045 (-0.98%)

EXEL Exelixis
$20.14 /

-0.11 (-0.54%)

EDAP EDAP TMS
$6.25 /

+0.255 (+4.25%)

CIDM Cinedigm
$2.16 /

+0.06 (+2.86%)

ACET Adicet Bio
$7.28 /

-0.47 (-6.06%)

ACER Acer Therapeutics
$2.53 /

-0.1 (-3.80%)

ABUS Arbutus Biopharma
$4.25 /

-0.005 (-0.12%)

  • 14
    Jul
  • 18
    Jun
  • 07
    May
  • 23
    Apr
  • 17
    Mar
  • 04
    Mar
  • 10
    Feb
  • 09
    Feb
  • 13
    Jan
  • 06
    Jan
  • 23
    Dec
  • 20
    Oct
  • 22
    Sep
  • 24
    Sep
ZYNE Zynerba
$4.31 /

-0.135 (-3.04%)

IMAB I-Mab
$68.57 /

+0.32 (+0.47%)

ZYNE Zynerba
$4.31 /

-0.135 (-3.04%)

TCON Tracon Pharmaceuticals
$3.73 /

-0.11 (-2.86%)

SLRX Salarius Pharmaceuticals
$1.03 /

+ (+0.00%)

RUBY Rubius Therapeutics
$19.44 /

-0.68 (-3.38%)

LYRA Lyra Therapeutics
$8.18 /

-0.37 (-4.33%)

LUMO Lumos Pharma
$10.10 /

-0.45 (-4.27%)

LPTX Leap Therapeutics
$1.79 /

+0.01 (+0.56%)

IMRA Imara
$4.12 /

-0.14 (-3.29%)

GMTX Gemini Therapeutics
$4.54 /

-0.045 (-0.98%)

EXEL Exelixis
$20.14 /

-0.11 (-0.54%)

EDAP EDAP TMS
$6.25 /

+0.255 (+4.25%)

CIDM Cinedigm
$2.16 /

+0.06 (+2.86%)

CGRN Capstone Green Energy
$4.45 /

-0.06 (-1.33%)

ANEB Anebulo Pharmaceuticals
$6.96 /

-0.06 (-0.85%)

AGRI AgriFORCE Growing Systems
$2.32 /

-0.19 (-7.57%)

ACET Adicet Bio
$7.28 /

-0.47 (-6.06%)

ABUS Arbutus Biopharma
$4.25 /

-0.005 (-0.12%)

ZYNE Zynerba
$4.31 /

-0.135 (-3.04%)

TARA Protara Therapeutics
$7.19 /

-0.46 (-6.01%)

KBNT Kubient
$3.50 /

+0.07 (+2.04%)

IMRA Imara
$4.12 /

-0.14 (-3.29%)

ACET Adicet Bio
$7.28 /

-0.47 (-6.06%)

ABUS Arbutus Biopharma
$4.25 /

-0.005 (-0.12%)

Hot Stocks
Cinedigm appoints John Canning as CFO » 11:09
09/14/21
09/14
11:09
09/14/21
11:09
CIDM

Cinedigm

$2.10 /

+0.005 (+0.24%)

Cinedigm announced that…

Cinedigm announced that John Canning has joined the Company as CFO, effective September 13, 2021. Canning will report to Chris McGurk, Chairman & CEO, and will be responsible for all financial functions at Cinedigm to support and enhance the Company's rapid growth trajectory. Prior to Cinedigm, Canning spent two years as the CFO of Firefly Systems Inc., an Ad-Tech startup in Silicon Valley, where he worked to secure funding, working capital and equipment financing.

ShowHide Related Items >><<
CIDM Cinedigm
$2.10 /

+0.005 (+0.24%)

CIDM Cinedigm
$2.10 /

+0.005 (+0.24%)

08/02/21 Alliance Global Partners
Cinedigm price target raised to $3.25 from $3.00 at Alliance Global Partners
05/12/21 Alliance Global Partners
Alliance Global Partners bullish on Cinedigm, sees Roku among catalysts
01/21/21 Alliance Global Partners
Cinedigm price target raised to $3 from $2 at Alliance Global Partners
10/16/20 Alliance Global Partners
Cinedigm initiated with a Buy at Alliance Global Partners
CIDM Cinedigm
$2.10 /

+0.005 (+0.24%)

CIDM Cinedigm
$2.10 /

+0.005 (+0.24%)

Conference/Events
H.C. Wainwright to hold a virtual conference » 09:30
09/14/21
09/14
09:30
09/14/21
09:30
ABUS

Arbutus Biopharma

$4.25 /

-0.145 (-3.30%)

, ACER

Acer Therapeutics

$2.61 /

-0.09 (-3.33%)

, ACET

Adicet Bio

$7.52 /

-0.16 (-2.08%)

, CIDM

Cinedigm

$2.10 /

+0.01 (+0.48%)

, TMDI

Titan Medical

$1.62 /

+0.05 (+3.19%)

, SLGG

Super League Gaming

$3.81 /

-0.08 (-2.06%)

, SLRX

Salarius Pharmaceuticals

$1.03 /

-0.025 (-2.37%)

, SMLR

Semler Scientific

$107.03 /

-2.72 (-2.48%)

, ZYNE

Zynerba

$4.44 /

-0.035 (-0.78%)

, TARA

Protara Therapeutics

$7.64 /

-0.12 (-1.55%)

, TCON

Tracon Pharmaceuticals

$3.85 /

-0.02 (-0.52%)

, RUBY

Rubius Therapeutics

$20.12 /

-0.83 (-3.96%)

, PLSE

Pulse Biosciences

$20.78 /

-0.14 (-0.67%)

, PNT

Point Biopharma

$9.15 /

-2.33 (-20.30%)

, IMRA

Imara

$4.26 /

-0.14 (-3.18%)

, IMAB

I-Mab

$68.25 /

-3.75 (-5.21%)

, KBNT

Kubient

$3.43 /

+0.13 (+3.94%)

, LPTX

Leap Therapeutics

$1.78 /

+0.31 (+21.16%)

, LUMO

Lumos Pharma

$10.64 /

-0.6 (-5.34%)

, LYRA

Lyra Therapeutics

$8.45 /

+ (+0.00%)

, EDAP

EDAP TMS

$6.00 /

+0.005 (+0.08%)

, EXEL

Exelixis

$20.25 /

+0.275 (+1.38%)

, GMTX

Gemini Therapeutics

$4.59 /

-0.1 (-2.13%)

, BLU

Bellus Health

$4.77 /

+0.84 (+21.37%)

, CGRN

Capstone Green Energy

$4.52 /

+0.01 (+0.22%)

, DYAI

Dyadic International

$5.78 /

+0.04 (+0.70%)

, AGRI

AgriFORCE Growing Systems

$2.51 /

-0.04 (-1.57%)

, ANEB

Anebulo Pharmaceuticals

$7.02 /

+0.12 (+1.74%)

, VIVE

Viveve

$2.46 /

-0.03 (-1.20%)

, ZIOP

Ziopharm

$1.83 /

-0.075 (-3.95%)

23rd Annual Global…

23rd Annual Global Investment Virtual Conference to be held on September 13-15.Webcast Link

ShowHide Related Items >><<
ZYNE Zynerba
$4.44 /

-0.035 (-0.78%)

ZIOP Ziopharm
$1.83 /

-0.075 (-3.95%)

VIVE Viveve
$2.46 /

-0.03 (-1.20%)

TMDI Titan Medical
$1.62 /

+0.05 (+3.19%)

TCON Tracon Pharmaceuticals
$3.85 /

-0.02 (-0.52%)

TARA Protara Therapeutics
$7.64 /

-0.12 (-1.55%)

SLRX Salarius Pharmaceuticals
$1.03 /

-0.025 (-2.37%)

SLGG Super League Gaming
$3.81 /

-0.08 (-2.06%)

RUBY Rubius Therapeutics
$20.12 /

-0.83 (-3.96%)

PNT Point Biopharma
$9.15 /

-2.33 (-20.30%)

PLSE Pulse Biosciences
$20.78 /

-0.14 (-0.67%)

LYRA Lyra Therapeutics
$8.45 /

+ (+0.00%)

LUMO Lumos Pharma
$10.64 /

-0.6 (-5.34%)

LPTX Leap Therapeutics
$1.78 /

+0.31 (+21.16%)

KBNT Kubient
$3.43 /

+0.13 (+3.94%)

IMRA Imara
$4.26 /

-0.14 (-3.18%)

IMAB I-Mab
$68.25 /

-3.75 (-5.21%)

GMTX Gemini Therapeutics
$4.59 /

-0.1 (-2.13%)

EXEL Exelixis
$20.25 /

+0.275 (+1.38%)

EDAP EDAP TMS
$6.00 /

+0.005 (+0.08%)

DYAI Dyadic International
$5.78 /

+0.04 (+0.70%)

CIDM Cinedigm
$2.10 /

+0.01 (+0.48%)

CGRN Capstone Green Energy
$4.52 /

+0.01 (+0.22%)

BLU Bellus Health
$4.77 /

+0.84 (+21.37%)

AGRI AgriFORCE Growing Systems
$2.51 /

-0.04 (-1.57%)

ACET Adicet Bio
$7.52 /

-0.16 (-2.08%)

ACER Acer Therapeutics
$2.61 /

-0.09 (-3.33%)

ABUS Arbutus Biopharma
$4.25 /

-0.145 (-3.30%)

ABUS Arbutus Biopharma
$4.25 /

-0.145 (-3.30%)

06/28/21 JMP Securities
Arbutus EASL updates still support progress in Chronic HBV, says JMP Securities
03/10/21 B. Riley
Arbutus Biopharma price target lowered to $7 from $8 at B. Riley Securities
12/17/20 H.C. Wainwright
Arbutus Biopharma initiated with a Buy at H.C. Wainwright
09/15/20 Chardan
Arbutus HBV data 'could represent a turning point,' says Chardan
ACER Acer Therapeutics
$2.61 /

-0.09 (-3.33%)

06/10/21 William Blair
Acer's increased pipeline visibility is encouraging, says William Blair
ACET Adicet Bio
$7.52 /

-0.16 (-2.08%)

05/17/21 BTIG
Adicet Bio initiated with a Buy at BTIG
05/17/21 BTIG
Adicet Bio initiated with a Buy at BTIG
04/29/21
Fly Intel: Top five analyst initiations
04/29/21 JonesTrading
Adicet Bio initiated with a Buy at JonesTrading
CIDM Cinedigm
$2.10 /

+0.01 (+0.48%)

08/02/21 Alliance Global Partners
Cinedigm price target raised to $3.25 from $3.00 at Alliance Global Partners
05/12/21 Alliance Global Partners
Alliance Global Partners bullish on Cinedigm, sees Roku among catalysts
01/21/21 Alliance Global Partners
Cinedigm price target raised to $3 from $2 at Alliance Global Partners
10/16/20 Alliance Global Partners
Cinedigm initiated with a Buy at Alliance Global Partners
TMDI Titan Medical
$1.62 /

+0.05 (+3.19%)

04/06/21 Oppenheimer
Opco starts 'attractive micro-cap play' Titan Medical with Outperform
04/06/21 Oppenheimer
Titan Medical initiated with an Outperform at Oppenheimer
SLGG Super League Gaming
$3.81 /

-0.08 (-2.06%)

05/27/21 H.C. Wainwright
Super League Gaming initiated with a Buy at H.C. Wainwright
03/01/21 Maxim
Super League Gaming initiated with a Buy at Maxim
03/01/21 Maxim
Super League Gaming initiated with a Buy at Maxim
02/09/21 Alliance Global Partners
Super League downgraded on 'rich' valuation at Alliance Global
SLRX Salarius Pharmaceuticals
$1.03 /

-0.025 (-2.37%)

08/25/21
Fly Intel: Top five analyst initiations
08/25/21 H.C. Wainwright
Salarius Pharmaceuticals initiated with a Buy at H.C. Wainwright
SMLR Semler Scientific
$107.03 /

-2.72 (-2.48%)

05/04/21 B. Riley
Semler Scientific price target raised to $151 from $147 at B. Riley
04/27/21 B. Riley
Semler Scientific transferred with Buy, $147 target at B. Riley
03/02/21 B. Riley
Semler Scientific price target raised to $147 from $121 at B. Riley Securities
02/25/21 B. Riley
Semler Scientific price target raised to $121 from $100 at B. Riley Securities
ZYNE Zynerba
$4.44 /

-0.035 (-0.78%)

06/25/21 Alliance Global Partners
Cannabis selloff brings buying opportunities, says Alliance Global
05/06/21 Cantor Fitzgerald
Zynerba price target raised to $8 from $6 at Cantor Fitzgerald
03/29/21 Stifel
Stifel says New York adult use cannabis market represents $5B opportunity
03/10/21 Roth Capital
Zynerba price target lowered to $7.25 from $8.00 at Roth Capital
TARA Protara Therapeutics
$7.64 /

-0.12 (-1.55%)

06/04/21 H.C. Wainwright
Protara Therapeutics initiated with a Buy at H.C. Wainwright
04/26/21 Oppenheimer
Protara Therapeutics price target lowered to $32 from $43 at Oppenheimer
10/19/20 Cowen
Protara Therapeutics initiated with an Outperform at Cowen
TCON Tracon Pharmaceuticals
$3.85 /

-0.02 (-0.52%)

06/04/21
Fly Intel: Top five analyst initiations
06/04/21 Alliance Global Partners
Tracon Pharmaceuticals initiated with a Buy at Alliance Global Partners
04/16/21 BTIG
BTIG upgrades Tracon to Buy with $14 target on Envafolimab progress
04/16/21 BTIG
Tracon Pharmaceuticals upgraded to Buy from Neutral at BTIG
RUBY Rubius Therapeutics
$20.12 /

-0.83 (-3.96%)

03/15/21 H.C. Wainwright
Rubius Therapeutics price target raised to $40 from $28 at H.C. Wainwright
10/14/20 JPMorgan
Rubius Therapeutics resumed with a Neutral at JPMorgan
PLSE Pulse Biosciences
$20.78 /

-0.14 (-0.67%)

07/26/21 Stephens
Pulse Biosciences a 'compelling and durable story,' says Stephens
07/26/21 Stephens
Pulse Biosciences initiated with an Overweight at Stephens
03/11/21 Maxim
Pulse Biosciences initiated with a Buy at Maxim
03/11/21 Maxim
Pulse Biosciences initiated with a Buy at Maxim
PNT Point Biopharma
$9.15 /

-2.33 (-20.30%)

07/29/21 Cowen
Cowen starts Point Biopharma at Outperform
07/29/21 Cowen
Point Biopharma initiated with an Outperform at Cowen
07/27/21 Jefferies
Point Biopharma initiated with a Hold at Jefferies
07/26/21 Piper Sandler
Point Biopharma initiated with an Overweight at Piper Sandler
IMRA Imara
$4.26 /

-0.14 (-3.18%)

08/11/21 Morgan Stanley
Imara downgraded to Equal Weight from Overweight at Morgan Stanley
08/11/21 Morgan Stanley
Imara downgraded to Equal Weight from Overweight at Morgan Stanley
03/08/21 SVB Leerink
Imara price target lowered to $42 from $59 at SVB Leerink
01/06/21 SVB Leerink
Imara selloff a potential buying opportunity, says SVB Leerink
IMAB I-Mab
$68.25 /

-3.75 (-5.21%)

09/03/21 Cantor Fitzgerald
Cantor Fitzgerald positive on I-Mab following 'solid' first half
09/01/21 H.C. Wainwright
I-Mab price target raised to $95 from $75 at H.C. Wainwright
07/26/21 Cantor Fitzgerald
I-Mab's overdone weakness a buying opportunity, says Cantor Fitzgerald
07/13/21 Cantor Fitzgerald
I-Mab price target raised to $95 from $90 at Cantor Fitzgerald
KBNT Kubient
$3.43 /

+0.13 (+3.94%)

08/17/21 Maxim
Kubient price target lowered to $9 from $13 at Maxim
03/26/21 Maxim
Kubient price target raised to $13 from $10 at Maxim
10/27/20 Maxim
Kubient initiated with a Buy at Maxim
LPTX Leap Therapeutics
$1.78 /

+0.31 (+21.16%)

09/13/21 Raymond James
Leap Therapeutics price target raised to $4 from $3 at Raymond James
09/13/21 Piper Sandler
Leap combo sees 'strong' early response rate, says Piper Sandler
06/03/21 Baird
Leap Therapeutics transferred with Outperform at Baird
05/17/21 Piper Sandler
Leap Therapeutics price target lowered to $4 from $6 at Piper Sandler
LUMO Lumos Pharma
$10.64 /

-0.6 (-5.34%)

08/05/21 Piper Sandler
Lumos shares trading below cash, says Piper Sandler
07/22/21 Roth Capital
Lumos Pharma price target lowered to $35 from $51 at Roth Capital
07/21/21 Piper Sandler
Piper says Lumos Pharma's OraGrowtH210 trial delay 'not a problem'
07/21/21 H.C. Wainwright
Lumos Pharma price target lowered to $27 from $34 at H.C. Wainwright
LYRA Lyra Therapeutics
$8.45 /

+ (+0.00%)

12/07/20 BofA
Lyra Therapeutics price target raised to $26 from $19 at BofA
EDAP EDAP TMS
$6.00 /

+0.005 (+0.08%)

04/28/21
Fly Intel: Top five analyst initiations
04/28/21 Piper Sandler
EDAP TMS initiated with an Overweight at Piper Sandler
04/01/21 H.C. Wainwright
EDAP TMS price target raised to $12 from $10 at H.C. Wainwright
01/25/21 Lake Street
EDAP TMS initiated with a Buy at Lake Street
EXEL Exelixis
$20.25 /

+0.275 (+1.38%)

08/06/21 H.C. Wainwright
Exelixis price target raised to $64 from $35 at H.C. Wainwright
06/29/21 H.C. Wainwright
Exelixis price target lowered to $35 from $47 at H.C. Wainwright
06/29/21 Oppenheimer
Exelixis price target lowered to $27 from $35 at Oppenheimer
06/28/21 Piper Sandler
Exelixis selloff on trial miss an overreaction, says Piper Sandler
GMTX Gemini Therapeutics
$4.59 /

-0.1 (-2.13%)

06/23/21 Stifel
Gemini's negative stock reaction to GEM103 data overdone, says Stifel
04/08/21 SVB Leerink
SVB Leerink bullish on Gemini Therapeutics, initiates with an Outperform
04/08/21 SVB Leerink
Gemini Therapeutics initiated with an Outperform at SVB Leerink
03/03/21 Jefferies
Gemini Therapeutics initiated with a Buy at Jefferies
BLU Bellus Health
$4.77 /

+0.84 (+21.37%)

09/14/21 BTIG
Bellus Health price target raised to $13 from $9 at BTIG
09/14/21 H.C. Wainwright
Bellus Health price target raised to $14 from $10 at H.C. Wainwright
07/29/21 BTIG
Bellus Health initiated with a Buy at BTIG
01/29/21 RBC Capital
Bellus Health initiated with an Outperform at RBC Capital
CGRN Capstone Green Energy
$4.52 /

+0.01 (+0.22%)

DYAI Dyadic International
$5.78 /

+0.04 (+0.70%)

AGRI AgriFORCE Growing Systems
$2.51 /

-0.04 (-1.57%)

ANEB Anebulo Pharmaceuticals
$7.02 /

+0.12 (+1.74%)

05/25/21 Benchmark
Anebulo Pharmaceuticals initiated with a Buy at Benchmark
VIVE Viveve
$2.46 /

-0.03 (-1.20%)

01/29/21 Alliance Global Partners
Viveve initiated with a Buy at Alliance Global Partners
ZIOP Ziopharm
$1.83 /

-0.075 (-3.95%)

08/10/21 Raymond James
Ziopharm downgraded to Market Perform from Outperform at Raymond James
08/10/21 Lake Street
Ziopharm price target lowered to $3.50 from $7 at Lake Street
08/10/21 Raymond James
Ziopharm downgraded to Market Perform from Outperform at Raymond James
08/09/21 Raymond James
Ziopharm downgraded to Market Perform from Outperform at Raymond James
ZYNE Zynerba
$4.44 /

-0.035 (-0.78%)

TCON Tracon Pharmaceuticals
$3.85 /

-0.02 (-0.52%)

TARA Protara Therapeutics
$7.64 /

-0.12 (-1.55%)

SLRX Salarius Pharmaceuticals
$1.03 /

-0.025 (-2.37%)

RUBY Rubius Therapeutics
$20.12 /

-0.83 (-3.96%)

PNT Point Biopharma
$9.15 /

-2.33 (-20.30%)

PLSE Pulse Biosciences
$20.78 /

-0.14 (-0.67%)

LYRA Lyra Therapeutics
$8.45 /

+ (+0.00%)

LUMO Lumos Pharma
$10.64 /

-0.6 (-5.34%)

LPTX Leap Therapeutics
$1.78 /

+0.31 (+21.16%)

KBNT Kubient
$3.43 /

+0.13 (+3.94%)

IMRA Imara
$4.26 /

-0.14 (-3.18%)

GMTX Gemini Therapeutics
$4.59 /

-0.1 (-2.13%)

EXEL Exelixis
$20.25 /

+0.275 (+1.38%)

EDAP EDAP TMS
$6.00 /

+0.005 (+0.08%)

CIDM Cinedigm
$2.10 /

+0.01 (+0.48%)

ACET Adicet Bio
$7.52 /

-0.16 (-2.08%)

ACER Acer Therapeutics
$2.61 /

-0.09 (-3.33%)

ABUS Arbutus Biopharma
$4.25 /

-0.145 (-3.30%)

  • 14
    Jul
  • 18
    Jun
  • 07
    May
  • 23
    Apr
  • 17
    Mar
  • 04
    Mar
  • 10
    Feb
  • 09
    Feb
  • 13
    Jan
  • 06
    Jan
  • 23
    Dec
  • 20
    Oct
  • 22
    Sep
  • 24
    Sep
ZYNE Zynerba
$4.44 /

-0.035 (-0.78%)

IMAB I-Mab
$68.25 /

-3.75 (-5.21%)

ZYNE Zynerba
$4.44 /

-0.035 (-0.78%)

TCON Tracon Pharmaceuticals
$3.85 /

-0.02 (-0.52%)

SLRX Salarius Pharmaceuticals
$1.03 /

-0.025 (-2.37%)

RUBY Rubius Therapeutics
$20.12 /

-0.83 (-3.96%)

LYRA Lyra Therapeutics
$8.45 /

+ (+0.00%)

LUMO Lumos Pharma
$10.64 /

-0.6 (-5.34%)

LPTX Leap Therapeutics
$1.78 /

+0.31 (+21.16%)

IMRA Imara
$4.26 /

-0.14 (-3.18%)

GMTX Gemini Therapeutics
$4.59 /

-0.1 (-2.13%)

EXEL Exelixis
$20.25 /

+0.275 (+1.38%)

EDAP EDAP TMS
$6.00 /

+0.005 (+0.08%)

CIDM Cinedigm
$2.10 /

+0.01 (+0.48%)

CGRN Capstone Green Energy
$4.52 /

+0.01 (+0.22%)

ANEB Anebulo Pharmaceuticals
$7.02 /

+0.12 (+1.74%)

AGRI AgriFORCE Growing Systems
$2.51 /

-0.04 (-1.57%)

ACET Adicet Bio
$7.52 /

-0.16 (-2.08%)

ABUS Arbutus Biopharma
$4.25 /

-0.145 (-3.30%)

ZYNE Zynerba
$4.44 /

-0.035 (-0.78%)

TARA Protara Therapeutics
$7.64 /

-0.12 (-1.55%)

KBNT Kubient
$3.43 /

+0.13 (+3.94%)

IMRA Imara
$4.26 /

-0.14 (-3.18%)

ACET Adicet Bio
$7.52 /

-0.16 (-2.08%)

ABUS Arbutus Biopharma
$4.25 /

-0.145 (-3.30%)

Hot Stocks
Cinedigm says The Film Detective acquires Holland Releasing's film, TV library » 09:43
09/07/21
09/07
09:43
09/07/21
09:43
CIDM

Cinedigm

$1.99 /

+ (+0.00%)

Cinedigm announced that…

Cinedigm announced that The Film Detective, the classic film restoration and streaming company, has acquired Los Angeles-based Holland Releasing's motion picture library of over 100 classic films and television shows. The expansive library includes rare archival film prints and negatives of such Hollywood classics as Frank Capra's Meet John Doe, Made for Each Other starring Carole Lombard and James Stewart, as well as Howard Hughes' grand scale, but controversial western, The Outlaw, starring Jane Russell. The library is wide ranging and includes science fiction, horror, and comedy titles. Thomas Holland, former Vice President of Columbia Pictures and Chief Operating Officer of Screen Gems, formed Holland Releasing in 1990 to produce and distribute television and theatrical programs.

ShowHide Related Items >><<
CIDM Cinedigm
$1.99 /

+ (+0.00%)

CIDM Cinedigm
$1.99 /

+ (+0.00%)

08/02/21 Alliance Global Partners
Cinedigm price target raised to $3.25 from $3.00 at Alliance Global Partners
05/12/21 Alliance Global Partners
Alliance Global Partners bullish on Cinedigm, sees Roku among catalysts
01/21/21 Alliance Global Partners
Cinedigm price target raised to $3 from $2 at Alliance Global Partners
10/16/20 Alliance Global Partners
Cinedigm initiated with a Buy at Alliance Global Partners
CIDM Cinedigm
$1.99 /

+ (+0.00%)

CIDM Cinedigm
$1.99 /

+ (+0.00%)

Hot Stocks
Cinedigm receives Nasdaq notice of deficiency » 17:13
09/02/21
09/02
17:13
09/02/21
17:13
CIDM

Cinedigm

$1.99 /

-0.09 (-4.34%)

Cinedigm announced that…

Cinedigm announced that on August 27, 2021, it received a notice from The Nasdaq Stock Market LLC indicating that it was no longer in compliance with Nasdaq Listing Rule 5250(c)(1) due to the failure to timely file its Quarterly Report on Form 10-Q for the quarter ended June 30, 2021 with the Securities and Exchange Commission. The Notice states that the company is required to submit a plan to regain compliance with Rule 5250(c)(1) within 60 calendar days from the date of the Notice. If the plan is accepted by Nasdaq, then Nasdaq can grant the company up to 180 calendar days from the due date of the Form 10-Q to regain compliance.

ShowHide Related Items >><<
CIDM Cinedigm
$1.99 /

-0.09 (-4.34%)

CIDM Cinedigm
$1.99 /

-0.09 (-4.34%)

08/02/21 Alliance Global Partners
Cinedigm price target raised to $3.25 from $3.00 at Alliance Global Partners
05/12/21 Alliance Global Partners
Alliance Global Partners bullish on Cinedigm, sees Roku among catalysts
01/21/21 Alliance Global Partners
Cinedigm price target raised to $3 from $2 at Alliance Global Partners
10/16/20 Alliance Global Partners
Cinedigm initiated with a Buy at Alliance Global Partners
CIDM Cinedigm
$1.99 /

-0.09 (-4.34%)

CIDM Cinedigm
$1.99 /

-0.09 (-4.34%)

Earnings
Cinedigm reports preliminary Q1 revenue $15M, one estimate $12.08M » 16:05
09/02/21
09/02
16:05
09/02/21
16:05
CIDM

Cinedigm

$2.01 /

-0.065 (-3.13%)

Total streaming minutes…

Total streaming minutes in the quarter increased to approximately 1.37B, a new company record, up 18% from 1.16B in the prior sequential quarter, and up 386% versus the prior year quarter. Total subscribers to the company's subscription video streaming services exceeded 679,000 subscribers in June, up approximately 38,000 subscribers or 6% over the prior sequential quarter and up 558,000 or 460% over the prior year quarter due to continued expansion of third-party and wholesale distribution deals. "We're in a great position. Our streaming revenues increased 181% this quarter and we have a very strong balance sheet having paid down all remaining Company debt shortly after quarter end. There is an enormous opportunity for Cinedigm to continue this rapid growth, all supported by an exceptional management team that we continue to enhance," said Chris McGurk, Cinedigm chairman and CEO.

ShowHide Related Items >><<
CIDM Cinedigm
$2.01 /

-0.065 (-3.13%)

CIDM Cinedigm
$2.01 /

-0.065 (-3.13%)

08/02/21 Alliance Global Partners
Cinedigm price target raised to $3.25 from $3.00 at Alliance Global Partners
05/12/21 Alliance Global Partners
Alliance Global Partners bullish on Cinedigm, sees Roku among catalysts
01/21/21 Alliance Global Partners
Cinedigm price target raised to $3 from $2 at Alliance Global Partners
10/16/20 Alliance Global Partners
Cinedigm initiated with a Buy at Alliance Global Partners
CIDM Cinedigm
$2.01 /

-0.065 (-3.13%)

CIDM Cinedigm
$2.01 /

-0.065 (-3.13%)

Hot Stocks
Cinedigm expands partnership with All3Media International » 09:31
08/23/21
08/23
09:31
08/23/21
09:31
CIDM

Cinedigm

$1.51 /

+ (+0.00%)

Cinedigm announced a deal…

Cinedigm announced a deal to launch The Only Way Is Essex channel, in partnership with All3Media International. The channel, devoted completely to the international reality sensation, expands Cinedigm's partnership with All3Media International, the leading independent television production & distribution company in the United Kingdom, beyond existing streaming channel So...Real that launched in 2020. The new 24/7 streaming channel will feature 13 seasons of the British reality series. The service will be available in the United States & Canada for linear and AVOD platforms on connected TVs, digital set-top boxes, media-streaming devices, as well as the web.

ShowHide Related Items >><<
CIDM Cinedigm
$1.51 /

+ (+0.00%)

CIDM Cinedigm
$1.51 /

+ (+0.00%)

08/02/21 Alliance Global Partners
Cinedigm price target raised to $3.25 from $3.00 at Alliance Global Partners
05/12/21 Alliance Global Partners
Alliance Global Partners bullish on Cinedigm, sees Roku among catalysts
01/21/21 Alliance Global Partners
Cinedigm price target raised to $3 from $2 at Alliance Global Partners
10/16/20 Alliance Global Partners
Cinedigm initiated with a Buy at Alliance Global Partners
CIDM Cinedigm
$1.51 /

+ (+0.00%)

CIDM Cinedigm
$1.51 /

+ (+0.00%)

Conference/Events
Sidoti to hold a virtual conference » 09:29
08/18/21
08/18
09:29
08/18/21
09:29
BLCT

BlueCity

$4.48 /

-0.43 (-8.76%)

, MG

Mistras

$9.53 /

-0.41 (-4.12%)

, VERO

Venus Concept

$1.91 /

-0.09 (-4.50%)

, BKTI

BK Technologies

$3.13 /

-0.05 (-1.57%)

, NVCN

Neovasc

/

+

, SOLR

GT Solar

/

+

, ALCO

Alico

$36.00 /

-0.62 (-1.69%)

, MINM

Minim

$2.32 /

-0.05 (-2.11%)

, CVGI

Commercial Vehicle Group

$9.08 /

-0.03 (-0.33%)

, FLOW

SPX Flow

$77.66 /

-0.4899 (-0.63%)

, OMQS

Omniq

$8.75 /

-0.25 (-2.78%)

, LCUT

Lifetime Brands

$17.72 /

-1.33 (-6.98%)

, VNRX

VolitionRx

$3.02 /

-0.16 (-5.03%)

, CSV

Carriage Services

$38.98 /

-0.96 (-2.40%)

, BWMX

Betterware de Mexico

$37.20 /

-0.38 (-1.01%)

, ARHH

Assure Holdings

$1.58 /

-0.10437 (-6.21%)

, BSET

Bassett Furniture

$21.17 /

-2.235 (-9.55%)

, CIDM

Cinedigm

$1.65 /

-0.03 (-1.79%)

, AUUD

Auddia

$3.04 /

-0.005 (-0.16%)

, INLB

Item 9 Labs

$1.81 /

+0.11 (+6.47%)

, RELL

Richardson Electronics

$7.50 /

-0.02 (-0.27%)

, AQMS

Aqua Metals

$2.10 /

-0.05 (-2.33%)

, VERB

Verb Technology

$1.71 /

-0.295 (-14.75%)

, LOCL

Local Bounti

/

+

, ABML

American Battery Metals

$1.44 /

-0.04 (-2.70%)

, NX

Quanex

$23.73 /

-0.705 (-2.89%)

Sidoti August Microcap…

Sidoti August Microcap Virtual Conference to be held on August 18-19. Webcast Link

ShowHide Related Items >><<
VNRX VolitionRx
$3.02 /

-0.16 (-5.03%)

VERO Venus Concept
$1.91 /

-0.09 (-4.50%)

VERB Verb Technology
$1.71 /

-0.295 (-14.75%)

OMQS Omniq
$8.75 /

-0.25 (-2.78%)

NVCN Neovasc
/

+

MINM Minim
$2.32 /

-0.05 (-2.11%)

MG Mistras
$9.53 /

-0.41 (-4.12%)

FLOW SPX Flow
$77.66 /

-0.4899 (-0.63%)

CVGI Commercial Vehicle Group
$9.08 /

-0.03 (-0.33%)

CIDM Cinedigm
$1.65 /

-0.03 (-1.79%)

BWMX Betterware de Mexico
$37.20 /

-0.38 (-1.01%)

BSET Bassett Furniture
$21.17 /

-2.235 (-9.55%)

BLCT BlueCity
$4.48 /

-0.43 (-8.76%)

BKTI BK Technologies
$3.13 /

-0.05 (-1.57%)

AUUD Auddia
$3.04 /

-0.005 (-0.16%)

ARHH Assure Holdings
$1.58 /

-0.10437 (-6.21%)

AQMS Aqua Metals
$2.10 /

-0.05 (-2.33%)

ALCO Alico
$36.00 /

-0.62 (-1.69%)

ABML American Battery Metals
$1.44 /

-0.04 (-2.70%)

BLCT BlueCity
$4.48 /

-0.43 (-8.76%)

06/22/21
Fly Intel: Top five analyst downgrades
06/22/21 Loop Capital
BlueCity cut to Hold at Loop Capital on 'more challenged' margin structure
06/22/21 Loop Capital
BlueCity downgraded to Hold from Buy at Loop Capital
12/10/20 Oppenheimer
BlueCity initiated with an Outperform, $20 target at Oppenheimer
MG Mistras
$9.53 /

-0.41 (-4.12%)

VERO Venus Concept
$1.91 /

-0.09 (-4.50%)

12/29/20 BTIG
Venus Concept flying under the radar, says BTIG
12/08/20 Stifel
Venus Concept initiated with a Hold at Stifel
12/08/20 Stifel
Venus Concept initiated with a Hold at Stifel
11/16/20 Oppenheimer
Venus Concept upgraded to Outperform with $4 target at Oppenheimer
BKTI BK Technologies
$3.13 /

-0.05 (-1.57%)

NVCN Neovasc
/

+

SOLR GT Solar
/

+

ALCO Alico
$36.00 /

-0.62 (-1.69%)

12/21/20 Roth Capital
Alico initiated with a Buy at Roth Capital
MINM Minim
$2.32 /

-0.05 (-2.11%)

08/06/21 B. Riley
B. Riley starts 'fast-growing' Minim with Buy, $4 target
08/06/21 B. Riley
Minim initiated with a Buy at B. Riley
CVGI Commercial Vehicle Group
$9.08 /

-0.03 (-0.33%)

05/06/21 Barrington
Barrington ups Commercial Vehicle Group target to $17 after quarterly results
11/10/20 Barrington
Commercial Vehicle Group price target raised to $8 from $5.50 at Barrington
08/26/20 Barrington
Commercial Vehicle Group price target raised to $5.50 from $5 at Barrington
FLOW SPX Flow
$77.66 /

-0.4899 (-0.63%)

07/19/21 Wolfe Research
Ingersoll-Rand, SPX Flow deal report 'credible,' says Wolfe Research
04/06/21 Barclays
SPX Flow price target raised to $58 from $54 at Barclays
03/31/21 Morgan Stanley
SPX Flow initiated with an Underweight at Morgan Stanley
03/12/21 RBC Capital
SPX Flow price target raised to $72 from $62 at RBC Capital
OMQS Omniq
$8.75 /

-0.25 (-2.78%)

04/09/21 Taglich Brothers
Omniq initiated with a Speculative Buy at Taglich Brothers
LCUT Lifetime Brands
$17.72 /

-1.33 (-6.98%)

06/11/21 DA Davidson
Lifetime Brands growth accelerating as investments bear fruit, says DA Davidson
12/17/20 DA Davidson
Lifetime Brands price target raised to $18 from $14 at DA Davidson
11/10/20 DA Davidson
Lifetime Brands upgraded to Buy from Neutral at DA Davidson
11/10/20 DA Davidson
Lifetime Brands upgraded to Buy from Neutral at DA Davidson
VNRX VolitionRx
$3.02 /

-0.16 (-5.03%)

03/09/21 Cantor Fitzgerald
VolitionRx initiated with an Overweight at Cantor Fitzgerald
11/13/20 Oppenheimer
VolitionRx vet test could be bridge with human tests delayed, says Oppenheimer
CSV Carriage Services
$38.98 /

-0.96 (-2.40%)

07/28/21 Roth Capital
Carriage Services 'simply too cheap' after 'strong' Q2, says Roth Capital
06/09/21 B. Riley
Carriage Services initiated with a Buy, $50 target at B. Riley
06/09/21 B. Riley
Carriage Services initiated with a Buy at B. Riley
05/05/21
Fly Intel: Top five analyst initiations
BWMX Betterware de Mexico
$37.20 /

-0.38 (-1.01%)

10/27/20 Telsey Advisory
Betterware de Mexico initiated with an Outperform at Telsey Advisory
ARHH Assure Holdings
$1.58 /

-0.10437 (-6.21%)

BSET Bassett Furniture
$21.17 /

-2.235 (-9.55%)

02/03/21
Fly Intel: Top five analyst initiations
02/03/21 Noble Capital
Bassett Furniture initiated with an Outperform at Noble Capital
01/14/21 Sidoti
Bassett Furniture price target raised to $26 from $23 at Sidoti
CIDM Cinedigm
$1.65 /

-0.03 (-1.79%)

08/02/21 Alliance Global Partners
Cinedigm price target raised to $3.25 from $3.00 at Alliance Global Partners
05/12/21 Alliance Global Partners
Alliance Global Partners bullish on Cinedigm, sees Roku among catalysts
01/21/21 Alliance Global Partners
Cinedigm price target raised to $3 from $2 at Alliance Global Partners
10/16/20 Alliance Global Partners
Cinedigm initiated with a Buy at Alliance Global Partners
AUUD Auddia
$3.04 /

-0.005 (-0.16%)

INLB Item 9 Labs
$1.81 /

+0.11 (+6.47%)

07/22/21 Noble Capital
Item 9 Labs initiated with an Outperform at Noble Capital
RELL Richardson Electronics
$7.50 /

-0.02 (-0.27%)

AQMS Aqua Metals
$2.10 /

-0.05 (-2.33%)

03/05/21 H.C. Wainwright
Aqua Metals initiated with a Buy at H.C. Wainwright
VERB Verb Technology
$1.71 /

-0.295 (-14.75%)

07/23/21 Alliance Global Partners
Verb Technology price target raised to $4 from $2.75 at Alliance Global
06/29/21 Ascendiant
Ascendiant starts Verb Technology with Buy, $4 price target
06/29/21 Ascendiant
Verb Technology initiated with a Buy at Ascendiant
01/13/21 Alliance Global Partners
Verb Technology price target raised to $2.75 from $2 at Alliance Global Partners
LOCL Local Bounti
/

+

ABML American Battery Metals
$1.44 /

-0.04 (-2.70%)

06/21/21 Alliance Global Partners
American Battery Metals initiated with a Buy at Alliance Global Partners
NX Quanex
$23.73 /

-0.705 (-2.89%)

09/04/20 CJS Securities
Quanex upgraded to Outperform from Market Perform at CJS Securities
VNRX VolitionRx
$3.02 /

-0.16 (-5.03%)

VERO Venus Concept
$1.91 /

-0.09 (-4.50%)

VERB Verb Technology
$1.71 /

-0.295 (-14.75%)

RELL Richardson Electronics
$7.50 /

-0.02 (-0.27%)

NX Quanex
$23.73 /

-0.705 (-2.89%)

NVCN Neovasc
/

+

MINM Minim
$2.32 /

-0.05 (-2.11%)

MG Mistras
$9.53 /

-0.41 (-4.12%)

LCUT Lifetime Brands
$17.72 /

-1.33 (-6.98%)

FLOW SPX Flow
$77.66 /

-0.4899 (-0.63%)

CVGI Commercial Vehicle Group
$9.08 /

-0.03 (-0.33%)

CSV Carriage Services
$38.98 /

-0.96 (-2.40%)

CIDM Cinedigm
$1.65 /

-0.03 (-1.79%)

BSET Bassett Furniture
$21.17 /

-2.235 (-9.55%)

ARHH Assure Holdings
$1.58 /

-0.10437 (-6.21%)

ALCO Alico
$36.00 /

-0.62 (-1.69%)

  • 29
    Jul
  • 07
    Jun
  • 17
    Feb
  • 10
    Feb
  • 22
    Dec
FLOW SPX Flow
$77.66 /

-0.4899 (-0.63%)

NX Quanex
$23.73 /

-0.705 (-2.89%)

MG Mistras
$9.53 /

-0.41 (-4.12%)

LOCL Local Bounti
/

+

FLOW SPX Flow
$77.66 /

-0.4899 (-0.63%)

CVGI Commercial Vehicle Group
$9.08 /

-0.03 (-0.33%)

CIDM Cinedigm
$1.65 /

-0.03 (-1.79%)

AUUD Auddia
$3.04 /

-0.005 (-0.16%)

RELL Richardson Electronics
$7.50 /

-0.02 (-0.27%)

AQMS Aqua Metals
$2.10 /

-0.05 (-2.33%)

Recommendations
Cinedigm price target raised to $3.25 from $3.00 at Alliance Global Partners » 07:57
08/02/21
08/02
07:57
08/02/21
07:57
CIDM

Cinedigm

$1.61 /

+0.04 (+2.55%)

Alliance Global Partners…

Alliance Global Partners analyst Brian Kintslinger raised the firm's price target on Cinedigm to $3.25 from $3.00 and reiterates a Buy rating on the shares post the fiscal Q4 results. The analyst believes Cinedigm is positioned to continue to enjoy accelerated growth given its "many catalysts" that include stronger inventory fill rates, more channels with better quality and increased viewership and subscriber counts.

ShowHide Related Items >><<
CIDM Cinedigm
$1.61 /

+0.04 (+2.55%)

CIDM Cinedigm
$1.61 /

+0.04 (+2.55%)

05/12/21 Alliance Global Partners
Alliance Global Partners bullish on Cinedigm, sees Roku among catalysts
01/21/21 Alliance Global Partners
Cinedigm price target raised to $3 from $2 at Alliance Global Partners
10/16/20 Alliance Global Partners
Cinedigm initiated with a Buy at Alliance Global Partners
CIDM Cinedigm
$1.61 /

+0.04 (+2.55%)

CIDM Cinedigm
$1.61 /

+0.04 (+2.55%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.